Ghrelin, diet, and pulmonary function

Chest

Volumn 128, Issue 3, 2005, Pages 1084-1086

  Zaloga, Gary P ^a,b,c  

^a Indiana University School of Medicine ^*

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFQUINOME; GHRELIN; NEUROPEPTIDE Y; NORADRENALIN;

APPETITE; BODY MASS; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DIETARY INTAKE; DRUG EFFECT; EDITORIAL; ENTEROCHROMAFFIN CELL; FOOD INTAKE; HUMAN; HYPOTHALAMUS; LUNG FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION; SATIETY;

EID: 24944524853     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1084     Document Type: Editorial

References (16)

1. Kojima M, Hosoda H, Dale Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from the stomach. Nature 1999; 402:656-660
2. Volante M, Fulcheri E, Allia E, et al. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 2002; 50:1013-1021
3. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87:2988-2991
4. Shimizu Y, Nagaya N, Teranishi Y, et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003; 310:830-835
5. Nagaya N, Uematsu M, Kojima M, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104:1430-1435
6. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002; 136:1146-1152
7. Okumura H, Nagaya N, Enomoto M, et al. Vasodilatory effects of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002; 39:779-783
8. Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R, et al. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2004; 287:H2885-H2890
9. Iglesias MJ, Pineiro R, Blanco M, et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004; 62:481-488
10. Nagaya N, Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 2003; 3:146-151
11. Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001; 280:R1483-R1487
12. King MK, Gay DM, Pan LC, et al. Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function. Circulation 2001; 103:308-313
13. Chang L, Zhao J, Li GZ, et al. Ghrelin protects myocardium from isoproterenol-induced injury in rats. Acta Pharmacologica Sinica 2004; 25:1131-1137
14. Baldanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI3-kinase/AKT. J Cell Biol 2002; 159:1029-1037
15. Itoh T, Nagaya N, Yoshikawa M, et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:879-882
16. Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005; 128:1187-1193